Product Images Pazopanib
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Pazopanib NDC 0480-4184 by Teva Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
new - pazopanib tablets 200 mg a217517 1
1 - pazopanib tablets 200 mg a217517 2
22 - pazopanib tablets 200 mg a217517 3
This text provides information on a proportion progression-free study comparing the effectiveness of Pazopanib (N = 246) versus Placebo (N = 123). The median progression-free survival for Pazopanib was 4.6 months, while for Placebo it was 1.6 months. The hazard ratio between the two groups was 0.35, with a 95% confidence interval of 0.26 to 0.48, indicating a significant difference between the two treatments.*
new - pazopanib tablets 200 mg a217517 4
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.